Research Progress on the Association Between GLP-1 Receptor Agonists and Cardiomyopathy
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a promising new class of drugs, whose clinical potential has recently been explored. Various preclinical studies and clinical trials initially demonstrated the efficacy of GLP-1RAs in treating type 2 diabetes mellitus (T2DM). However, long-ter...
| 发表在: | Reviews in Cardiovascular Medicine |
|---|---|
| Main Authors: | , |
| 格式: | 文件 |
| 语言: | 英语 |
| 出版: |
IMR Press
2025-08-01
|
| 主题: | |
| 在线阅读: | https://www.imrpress.com/journal/RCM/26/8/10.31083/RCM37180 |